SYNGENE - IntraDay Trade Analysis with Live Signals
Back to ListIntraDay Trade Rating: 2.3
| Stock Code | SYNGENE | Market Cap | 19,009 Cr. | Current Price | 472 ₹ | High / Low | 761 ₹ |
| Stock P/E | 49.6 | Book Value | 115 ₹ | Dividend Yield | 0.26 % | ROCE | 12.8 % |
| ROE | 9.78 % | Face Value | 10.0 ₹ | DMA 50 | 591 ₹ | DMA 200 | 649 ₹ |
| Chg in FII Hold | -1.35 % | Chg in DII Hold | 1.21 % | PAT Qtr | 68.7 Cr. | PAT Prev Qtr | 66.2 Cr. |
| RSI | 16.9 | MACD | -47.0 | Volume | 7,67,650 | Avg Vol 1Wk | 12,23,246 |
| Low price | 456 ₹ | High price | 761 ₹ | PEG Ratio | 38.4 | Debt to equity | 0.07 |
| 52w Index | 5.24 % | Qtr Profit Var | -44.2 % | EPS | 8.22 ₹ | Industry PE | 78.8 |
📊 Analysis: SYNGENE shows weak intraday potential. Current price (472 ₹) is well below both 50 DMA (591 ₹) and 200 DMA (649 ₹), reflecting strong bearish pressure. RSI at 16.9 indicates oversold conditions, but MACD at -47.0 confirms deep bearish momentum. Volume (7.67 lakh) is below the 1-week average (12.23 lakh), showing reduced participation. The stock trades at only 5.24% of its 52-week high, reflecting poor sentiment and weak technicals.
💰 Optimal Buy Price: 465–470 ₹ (near short-term support).
📈 Profit-Taking Exit Levels: 480–490 ₹ (short-term resistance).
🛑 Stop-Loss / Loss Protection: 460 ₹ (below support zone).
⏱️ If Already Holding: Exit intraday if price fails to sustain above 472 ₹ or if MACD remains negative with no sign of reversal. Book profits if price approaches 480–490 ₹ but volume remains weak or RSI fails to recover.
✅ Positive
- EPS at 8.22 ₹ indicates earnings presence.
- DII holdings increased (+1.21%).
- Low debt-to-equity ratio (0.07) reflects financial stability.
⚠️ Limitation
- Price trading far below both 50 DMA and 200 DMA, showing strong bearish trend.
- RSI at 16.9 indicates oversold but also weak momentum.
- MACD negative (-47.0), confirming bearish bias.
- PEG ratio at 38.4 suggests expensive valuation relative to growth.
- Volume below average, limiting intraday opportunities.
📉 Company Negative News
- Quarterly PAT declined (68.7 Cr vs 66.2 Cr previously, -44.2% variation).
- FII holdings decreased (-1.35%).
- ROE (9.78%) and ROCE (12.8%) are modest compared to peers.
📈 Company Positive News
- DII inflows (+1.21%) show domestic institutional confidence.
- Stable EPS at 8.22 ₹ despite weak performance.
🏭 Industry
- Industry PE at 78.8, higher than SYNGENE’s P/E of 49.6, suggesting relative undervaluation.
- Biotech and pharma sector remains in long-term growth phase, supported by R&D demand.
🔎 Conclusion
SYNGENE is a weak candidate for intraday trading today. Technical indicators show strong bearish bias with price far below moving averages, negative MACD, and oversold RSI. A cautious buy near 465–470 ₹ with exit around 480–490 ₹ is possible, but strict stop-loss at 460 ₹ is essential. Traders should remain conservative due to poor sentiment and weak fundamentals.